MED12 mutations were not associated with distant recurrences (MED12 mutations in cases vs controls: 2/8 vs 1/8; OR: 0.45; 95% CI: 0.01-10.79; P-value > .99) nor with the presence of fibroadenoma-like areas (MED12 mutations in FLA+ vs FLA-: 1/8 vs 2/8; OR: 2.21; 95% CI: 0.09%-156.81; P-value > .99). The gene discussed is MED12; the disease is Fibroadenoma.